Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification

Pharmacology

Volumn 81, Issue 2, 2008, Pages 92-96

  Glasper, Anthony ^a,b   Gossop, Michael ^a   De Wet, Cornelis ^a   Reed, Laurence ^a   Bearn, Jennifer ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Hastings and Rother Substance Misuse Service   (United Kingdom)

Author keywords

Anxiety, opiate withdrawal syndrome; Methadone detoxification; Opiate dependence; Opiate withdrawal syndrome

Indexed keywords

METHADONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DETOXIFICATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HUMAN; LENGTH OF STAY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; VARIANCE; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; LENGTH OF STAY; MALE; METHADONE; OPIOID-RELATED DISORDERS; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 38749140254     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109982     Document Type: Article

References (19)

1. Kalivas PW, Volkow ND: Neural basis of addiction: pathology of motivation and choice. Am J Psychiatry 2005;162:1403-1413.
2. Jaffe JH: Opioid-related disorders; in Kaplan HI, Saddock BJ (eds): Comprehensive Textbook of Psychiatry, ed 6. Baltimore, Williams & Wilkins, 1995, pp 842-864.
3. Parfitt K (ed): Martindale: The Complete Drug Reference, ed 32. London, Pharmaceutical Press, 1999, p 67.
4. Department of Health: Drug Misuse and Dependence - Guidelines on Clinical Management. London, Department of Health, 1999.
5. Strang J, Gossop M: Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts. Addict Behav 1990;15:541-547.
6. Gossop M, Griffiths P, Bradley M, Strang J: Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes. Br J Psychiatry 1989;154:360-363.
7. Glasper A, Reed LJ, de Wet CJ, Gossop M, Bearn J: Induction of patients with moderately severe methadone dependence onto buprenorphine. Addict Biol 2005;10:149-155.
8. Gossop M, Strang J: A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Br J Psychiatry 1991;158:697-699.
9. Gossop M, Bradley B, Phillips GT: An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addict Behav 1987;12:1-6.
10. Phillips GT, Gossop M, Bradley B: The influence of psychological factors on the opiate withdrawal syndrome. Br J Psychiatry 1986;149:235-238.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4 revised. Washington, American Psychiatric Association, 2000.
12. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J: The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998;93:1857-1867.
13. Gossop M: The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990;15:487-490.
14. Andrews HL, Himmelsbach CK: Relation of intensity of the morphine abstinence syndrome to dosage. J Pharmacol Exp Ther 1944;81:288-293.
15. Smolka M, Schmidt LG: The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction 1999;94:1191-1198.
16. Gossop M, Marsden J, Stewart D, Lehmann P, Edwards C, Wilson A, Segar G: Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998;173:166-171.
17. de Wet C, Reed L, Glasper A, Moran P, Bearn J, Gossop M: Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome. Drug Alcohol Depend 2004;76:31-35.
18. Madlung E, Haring C, Crespo JA, Saria A, Grubinger P, Zernig G: Methadone doses upon multiple readmissions to inpatient detoxification: clinical evidence for very moderate opioid tolerance. Pharmacology 2006;78:38-43.
19. Green L, Gossop M: Effects of information on the opiate withdrawal syndrome. Br J Addict 1988;83:305-309.